{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:10:48Z","timestamp":1793394648531,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71325-2","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T13:05:37Z","timestamp":1725282337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute-phase proteins as indicators of disease severity and mortality in COVID-19 patients"],"prefix":"10.1038","volume":"14","author":[{"given":"Lech","family":"Chrostek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacper","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kazberuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Kralisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gruszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatol","family":"Panasiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Cylwik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"71325_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882000165X","volume":"148","author":"L Li","year":"2020","unstructured":"Li, L. & Chen, C. Contribution of acute-phase reaction proteins to the diagnosis and treatment of 2019 novel coronavirus disease (COVID-19). Epidemiol. Infect. 148, e164 (2020).","journal-title":"Epidemiol. Infect."},{"key":"71325_CR2","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1515\/hsz-2021-0209","volume":"402","author":"C Ehlting","year":"2021","unstructured":"Ehlting, C., Wolf, S. D. & Bode, J. G. Acute-phase protein synthesis: A key feature of innate immune functions of the liver. Biol. Chem. 402, 1129\u20131145 (2021).","journal-title":"Biol. Chem."},{"key":"71325_CR3","first-page":"84","volume":"25","author":"SB Dowton","year":"1988","unstructured":"Dowton, S. B. & Colten, H. R. Acute phase reactants in inflammation and infection. Semin. Hematol. 25, 84\u201390 (1988).","journal-title":"Semin. Hematol."},{"key":"71325_CR4","first-page":"739","volume":"97","author":"I Kushner","year":"1981","unstructured":"Kushner, I., Gewurz, H. & Benson, M. D. C-reactive protein and the acute-phase response. J. Lab. Clin. Med. 97, 739\u2013749 (1981).","journal-title":"J. Lab. Clin. Med."},{"key":"71325_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.nu.14.070194.002431","volume":"14","author":"Y Ingenbleek","year":"1994","unstructured":"Ingenbleek, Y. & Young, V. Transthyretin (prealbumin) in health and disease: Nutritional implications. Annu. Rev. Nutr. 14, 495\u2013533 (1994).","journal-title":"Annu. Rev. Nutr."},{"key":"71325_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.15324\/kjcls.2021.53.3.201","volume":"53","author":"M Fazal","year":"2021","unstructured":"Fazal, M. C-reactive protein a promising biomarker of COVID-19 severity. Korean J. Clin. Lab. Sci. 53, 201\u2013207 (2021).","journal-title":"Korean J. Clin. Lab. Sci."},{"key":"71325_CR7","doi-asserted-by":"publisher","first-page":"720363","DOI":"10.3389\/fimmu.2021.720363","volume":"12","author":"YY Luan","year":"2021","unstructured":"Luan, Y. Y., Yin, C. H. & Yao, Y. M. Update advances on C-reactive protein in COVID-19 and other viral infections. Front. Immunol. 12, 720363 (2021).","journal-title":"Front. Immunol."},{"key":"71325_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/1354750X.2020.1797880","volume":"25","author":"K Kappert","year":"2020","unstructured":"Kappert, K., Jahi\u0107, A. & Tauber, R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers 25, 616\u2013625 (2020).","journal-title":"Biomarkers"},{"key":"71325_CR9","doi-asserted-by":"publisher","first-page":"175346662093717","DOI":"10.1177\/1753466620937175","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang, I., Pranata, R., Lim, M. A., Oehadian, A. & Alisjahbana, B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: A meta-analysis. Ther. Adv. Respir. Dis. 14, 1753466620937175 (2020).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"71325_CR10","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","volume":"127","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J. Clin. Virol. 127, 104370 (2020).","journal-title":"J. Clin. Virol."},{"key":"71325_CR11","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2021.210720","author":"H Topcu","year":"2022","unstructured":"Topcu, H. & Arik, Y. E. The importance of D-dimer, ferritin, CRP and lymphocyte values in determining mortality in COVID-19 disease in Turkey. Clin. Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2021.210720 (2022).","journal-title":"Clin. Lab."},{"key":"71325_CR12","first-page":"628","volume":"121","author":"B Yormaz","year":"2020","unstructured":"Yormaz, B. et al. The evaluation of prognostic value of acute phase reactants in the COVID-19. Bratisl. Lek. Listy 121, 628\u2013633 (2020).","journal-title":"Bratisl. Lek. Listy"},{"key":"71325_CR13","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946202163051","volume":"63","author":"AT Sayit","year":"2021","unstructured":"Sayit, A. T., Elmali, M., Deveci, A. & Gedikli, O. Relationship between acute phase reactants and prognosis in patients with or without COVID-19 pneumonia. Rev. Inst. Med. Trop. Sao Paulo 63, e51 (2021).","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"71325_CR14","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.100488","volume-title":"Role of Transferrin in Iron Metabolism [Internet]. Iron Metabolism\u2014A Double-Edged Sword","author":"NC Giri","year":"2022","unstructured":"Giri, N. C. Role of Transferrin in Iron Metabolism [Internet]. Iron Metabolism\u2014A Double-Edged Sword (IntechOpen, 2022). https:\/\/doi.org\/10.5772\/intechopen.100488."},{"key":"71325_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3947\/ic.2022.0162","volume":"54","author":"JH Kim","year":"2022","unstructured":"Kim, J. H. Clinical utility of procalcitonin on antibiotic stewardship: A narrative review. Infect. Chemother. 54, 610\u2013620 (2022).","journal-title":"Infect. Chemother."},{"key":"71325_CR16","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3390\/jcm9061753","volume":"9","author":"J Baj","year":"2020","unstructured":"Baj, J. et al. COVID-19: Specific and non-specific clinical manifestations and symptoms: The current state of knowledge. J. Clin. Med. 9, 1753 (2020).","journal-title":"J. Clin. Med."},{"key":"71325_CR17","doi-asserted-by":"publisher","first-page":"663P","DOI":"10.1093\/bja\/84.5.663","volume":"84","author":"C Stenhouse","year":"1999","unstructured":"Stenhouse, C., Coates, S., Tivey, M., Allsop, P. & Parker, T. Prospective evaluation of a modified early warning score to aid earlier detection of patients developing critical illness on a general surgical ward. Br. J. Anaesth. 84, 663P (1999).","journal-title":"Br. J. Anaesth."},{"key":"71325_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/qjmed\/94.10.521","volume":"94","author":"CP Subbe","year":"2001","unstructured":"Subbe, C. P., Kruger, M., Rutherford, P. & Gemmel, L. Validation of a modified early warning score in medical admissions. QJM 94, 521\u2013526 (2001).","journal-title":"QJM"},{"issue":"1 Pt 2","key":"71325_CR19","first-page":"1216","volume":"25","author":"JL Ferrara","year":"1993","unstructured":"Ferrara, J. L., Abhyankar, S. & Gilliland, D. G. Cytokine storm of graft-versus-host disease: A critical effector role for interleukin-1. Transplant. Proc. 25(1 Pt 2), 1216\u20131217 (1993).","journal-title":"Transplant. Proc."},{"key":"71325_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","volume":"53","author":"EO Gubernatorova","year":"2020","unstructured":"Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I. & Drutskaya, M. S. IL-6: Relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 53, 13\u201324 (2020).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"S2","key":"71325_CR21","volume":"23","author":"S Orhan","year":"2021","unstructured":"Orhan, S. et al. The effect of acute phase reactants on the survival of COVID-19 patients in intensive care. Progr. Nutr. 23(S2), e2021268 (2021).","journal-title":"Progr. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71325-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T13:29:45Z","timestamp":1725283785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71325"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71325-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20360"}}